Login / Signup

Use of immunohistochemical biomarkers as independent predictor of neoplastic progression in Barrett's oesophagus surveillance: A systematic review and meta-analysis.

Vincent T JanmaatSophie H van OlphenKatharina E BiermannLeendert H J LooijengaMarco B BrunoManon C W Spaander
Published in: PloS one (2017)
Use of p53 IHC staining may improve risk stratification in BE surveillance. Aberrant p53 expression in BE patients appeared to be associated with a significantly increased risk of neoplastic progression for both non-dysplastic and LGD BE patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • public health
  • peritoneal dialysis
  • prognostic factors
  • patient reported